申请人:Incyte Holdings Corporation
公开号:EP3466953A1
公开(公告)日:2019-04-10
The present invention provides the use of 3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile in the preparation of a medicament for use in the treatment of graft versus host disease.
本发明提供了 3-环戊基-3-[4-(7H-吡咯并[2,3-]嘧啶-4-基)-1H-吡唑-1-基]丙腈在制备用于治疗移植物抗宿主疾病的药物中的用途。